Stock Analysis on Net
Stock Analysis on Net

Merck & Co. Inc. (NYSE:MRK)

Common-Size Income Statement

Merck & Co. Inc., common-size consolidated income statement

Microsoft Excel
12 months ended: Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Sales 100.00 100.00 100.00 100.00 100.00
Cost of sales -23.68 -26.83 -29.37 -27.98 -32.26
Gross profit 76.32% 73.17% 70.63% 72.02% 67.74%
Selling, general and administrative -16.86 -17.47 -16.94 -19.78 -21.81
Research and development -27.95 -50.79 -22.85 -25.14 -28.25
Restructuring costs -0.48 -1.00 -0.57 -1.36 -1.20
Operating income 31.03% 3.92% 30.27% 25.74% 16.47%
Interest income 0.65 0.61 0.26 0.07 0.12
Interest expense -1.98 -1.91 -1.62 -1.65 -1.73
Exchange losses -0.35 -0.62 -0.40 -0.61 -0.30
Income (loss) from investments in equity securities, net 0.02 0.57 -2.39 3.98 2.79
Net periodic defined benefit plan credit other than service cost 0.99 0.83 0.47 0.44 0.71
Other, net 0.72 -0.25 1.15 0.53 0.26
Other income (expense), net 0.04% -0.78% -2.53% 2.75% 1.85%
Income from continuing operations before taxes 31.07% 3.14% 27.74% 28.50% 18.32%
Taxes on income from continuing operations -4.37 -2.52 -3.24 -3.12 -3.56
Net income from continuing operations 26.70% 0.63% 24.50% 25.37% 14.76%
Income from discontinued operations, net of taxes 0.00 0.00 0.00 1.45 0.00
Net income 26.70% 0.63% 24.50% 26.82% 14.76%
Net income attributable to noncontrolling interests -0.02 -0.02 -0.01 -0.03 -0.03
Net income attributable to Merck & Co., Inc. 26.68% 0.61% 24.49% 26.79% 14.72%

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Income statement item Description The company
Operating income The net result for the period of deducting operating expenses from operating revenues. Merck & Co. Inc. operating income as a percentage of sales decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level.
Income from continuing operations before taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Merck & Co. Inc. income from continuing operations before taxes as a percentage of sales decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level.
Net income attributable to Merck & Co., Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Merck & Co. Inc. net income attributable to Merck & Co., Inc. as a percentage of sales decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level.